feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    UID:
    almahu_BV046835421
    Format: 1 Online-Ressource (XIII, 519 Seiten) : , Illustrationen.
    ISBN: 978-3-030-43073-3
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-030-43072-6
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-030-43074-0
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-030-43075-7
    Language: English
    URL: Volltext  (URL des Erstveröffentlichers)
    URL: Volltext  (URL des Erstveröffentlichers)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    UID:
    b3kat_BV046835421
    Format: 1 Online-Ressource (XIII, 519 Seiten) , Illustrationen
    ISBN: 9783030430733
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-030-43072-6
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-030-43074-0
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-030-43075-7
    Language: English
    URL: Volltext  (URL des Erstveröffentlichers)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    UID:
    kobvindex_ZLB15690498
    Format: XII, 212 Seiten , graph. Darst.
    ISBN: 978-1-4614-0048-6
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    UID:
    edoccha_BV046835421
    Format: 1 Online-Ressource (XIII, 519 Seiten) : , Illustrationen.
    ISBN: 978-3-030-43073-3
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-030-43072-6
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-030-43074-0
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-030-43075-7
    Language: English
    URL: Volltext  (URL des Erstveröffentlichers)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    UID:
    edocfu_BV046835421
    Format: 1 Online-Ressource (XIII, 519 Seiten) : , Illustrationen.
    ISBN: 978-3-030-43073-3
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-030-43072-6
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-030-43074-0
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-030-43075-7
    Language: English
    URL: Volltext  (URL des Erstveröffentlichers)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    UID:
    almahu_9949419453302882
    Format: XII, 212 p. , online resource.
    Edition: 1st ed. 2011.
    ISBN: 9781461400493
    Content: The last 10 years have seen a seismic shift in therapeutic product development and testing. In both the pharmaceutical (both small and large molecule) and medical device sectors, the vast majority of testing and evaluation of products is not performed within innovator companies, but rather has been outsourced to a growing universe of commercial organizations. The authors both have more than 30 years experience in this field, and both have worked within innovator companies, for CROs, and as consultants in the field.  Contract Research and Development Organizations: Their Role in Global Product Development has been crafted by these authors to provide a how to guide for all aspects of working with CROs in selecting, working with and ensuring the best possible desirable outcome of having the R&D function, or substantial parts of it, outsourced.   It uses as the exemplary case nonclinical safety assessment, biocompatibility and efficacy testing which are to be performed to select the best possible candidate compound, device or formulation and then moving the resulting regulated therapeutic medical product into and through the development process and to marketing approval. But also covered are the contract synthesis of drug substances and corresponding manufacture of biologics and manufacture of products, formulation development, clinical evaluation, regulatory and document preparation support, and use of consultants. Included in the volume are an exhaustive listing of those CROs in the (drug and device) safety evaluation sector and their contact information and capabilities, and extensive similar listing for the other types of contract service providers. Also included are guidances on how to monitor ongoing work at contract facilities and audit check lists for GLP, GMP and GCP facilities. These listings are international in scope, and a specific chapter addresses working with some of the newer international CROs.
    Note: Introduction -- The pharmaceutical Development Process & Testing Requirements -- The Medical Device Development Process & Testing Requirements -- Functions and Types of CROs (referencing function listings in appendices) -- Selection of CROs -- Labs in China and India -- Contracting, Pricing, and Cost of Works Performed by CROs -- Monitoring Ongoing Studies and Work -- Common Problems and their Solutions -- Appendix.
    In: Springer Nature eBook
    Additional Edition: Printed edition: ISBN 9781461400486
    Additional Edition: Printed edition: ISBN 9781489998903
    Additional Edition: Printed edition: ISBN 9781461400509
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    New York, NY : Springer Science+Business Media, LLC
    UID:
    gbv_1651286159
    Format: Online-Ressource (XII, 212p. 4 illus, digital)
    Edition: 1
    ISBN: 9781461400493
    Series Statement: SpringerLink
    Content: Charles B. Spainhour
    Content: The last 10 years have seen a seismic shift in therapeutic product development and testing. In both the pharmaceutical (both small and large molecule) and medical device sectors, the vast majority of testing and evaluation of products is not performed within innovator companies, but rather has been outsourced to a growing universe of commercial organizations. The authors both have more than 30 years experience in this field, and both have worked within innovator companies, for CROs, and as consultants in the field. "Contract Research and Development Organizations: Their Role in Global Pro
    Note: Includes bibliographical references and index , Contract Research and Development Organizations; Preface; Contents; Chapter 1: Introduction; Chapter 2: Pharmaceutical Development; Chapter 3: Medical Device Development; Chapter 4: Functions and Types of CROs; Chapter 5: Selection of CRDOs; Chapter 6: CROs in China, India, and Elsewhere in the Broader World: Outsourcing Science Gone Global; Chapter 7: Contracting, Pricing, and Cost of Works Performed by CROs; Chapter 8: Monitoring Ongoing Studies and Work; Chapter 9: Common Problems and Solutions; Appendix AToxicology Labs; Appendix B Medical Device Labs; Appendix CPhase I Labs , Appendix DAnalytical LabsAppendix E GMP Contract Facilities; Appendix FFormulation; Appendix G Dosage Forms; Appendix HClinical Testing; Appendix IRegulatory Services; Appendix J Contract Laboratory Audit Check List; Appendix KContract Manufacturer Audit Check List; Appendix LContract Laboratory Audit Check List (GCP); About the Author; Index;
    Additional Edition: ISBN 9781461400486
    Additional Edition: Buchausg. u.d.T. ISBN 978-1-461-40048-6
    Language: English
    Keywords: Auftragsforschung ; Arzneimittelentwicklung ; Pharmazeutische Industrie ; Outsourcing
    URL: Volltext  (lizenzpflichtig)
    URL: Cover
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    UID:
    gbv_1726028143
    Format: 1 Online-Ressource(XIII, 519 p. 19 illus., 1 illus. in color.)
    Edition: 1st ed. 2020.
    ISBN: 9783030430733
    Content: Introduction -- History of CROs: Including CRO Snapshots and a CRO Genealogy Chart -- The Pharmaceutical Development Process & Testing Requirements -- The Medical Device Development Process & Testing Requirements -- Functions and Types of CROs -- Labs in China and India -- Selection of CROs -- Study Directors and PIs -- Nuts and Bolts of Study Performance SCG/CBS -- Electronic Reporting Requirements (SEND & eCTD) -- Study and Project Monitoring -- Contracting, Pricing, and Cost of Works Performed by CROs -- Consultants and their Role -- Building Relationships: Maximizing your return on Expectations with a CRO -- Common Problems and their Solutions -- Appendices: A Toxicology Labs B Medical Device Labs C Phase I Labs D Analytical Labs E GMP Contract Facilities F Formulation G Dosage Forms H Clinical Testing I Regulatory Services J Forms and Checklists -- K Specialized Services -- L Consultants Known to be In-Practice -- Index. .
    Content: This volume provides a complete update of all the materials in prior volumes on the subject (including current directories to testing labs and other support establishments worldwide), while adding substantial new material on the following topics: · The history of CROs, including snapshots of CROs and a genealogy chart making clear where they came from and where they went. · Study directors and principal investigators. · The nuts and bolts of study performance. · Electronic reporting requirements – SEND and eCTD (required for NDA, BLA, ANDA, and IND submissions). · Consultants and their roles. · An expanded examination of common problems and their solutions. This book boasts complete directories to the global universe of operating labs – where they are, how to contact them, and what they do (including special capabilities). Additionally, checklists for qualifying labs and manufacturing facilities – and for auditing studies and projects at such facilities – are included. It is directed at those in industry (specifically directed at those working for companies using CRO services) but will also be of interest to scientists or administrators working in research organizations themselves. In this case, the contents of this new work are essential to the target reader because the work, regulations, and actors (CROs) have evolved and changed at a rapid pace in the 10 years since the earlier volume that the author published. Likewise, the companies using these services have come to all be almost completely dependent on outsourcing. The earlier texts remain the only source of their kind (paper or electronic) on the field and the only noncommercial guide to the global industry and this volume provides a complete update.
    Additional Edition: ISBN 9783030430726
    Additional Edition: ISBN 9783030430740
    Additional Edition: ISBN 9783030430757
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 9783030430726
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 9783030430740
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 9783030430757
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    UID:
    almahu_9949865736502882
    Format: 1 online resource (421 pages)
    Edition: 1st ed.
    ISBN: 9781351643610 , 1351643614
    Note: Cover -- Half title -- Title page -- Copyright -- Dedication -- Contents -- Preface -- About the Author -- Chapter 1: Introduction -- Receptor Theory of Drug Efficacy and Drug Toxicity -- References -- Chapter 2: Pharmacotherapy, Toxicodynamics, and Regulatory Science -- Divergent Objectives -- Introduction -- References -- Chapter 3: Nonclinical Pharmacokinetics and Toxicokinetics -- A Primer -- Introduction -- Regulations -- Principles -- Preliminary Work -- Absorption -- Absorption from the Pulmonary System -- Absorption across the Skin -- Parameters Controlling Absorption -- Distribution -- Protein Binding -- Water Solubility -- Volume of Distribution -- Metabolism/Biotransformation -- Metabolic Activation -- Induction of P-450 Metabolism and Isoenzymes -- Species Differences -- Sex-Related Differences in Rodents -- Excretion -- Urine -- Feces -- Expired Air -- Pharmacokinetics -- Sampling Methods and Intervals -- Blood -- Excreta -- Bile -- Expired Air -- Milk -- Analysis of Data -- Use of Data from Metabolism and Pharmacokinetic Studies -- Physiologically Based Pharmacokinetic (PBPK) Modeling -- Points to Consider -- Biologically Derived Materials -- Immunoassay Methods -- Metabolism and Elimination -- Points to Consider -- References -- Chapter 4: Routes of Administration: With Considerations for Species Specificity -- Bioavailability and Thresholds -- Dermal Route -- Parenteral Route -- Intravenous Route (IV) -- Bolus versus Infusion -- Intramuscular Route (IM) -- Subcutaneous Route (SC) -- Intraperitoneal Route (IP) -- Oral Routes (PO) -- Mechanisms of Absorption -- Factors Affecting Oral Absorption -- Techniques of Oral Administration -- Buccal and Sublingual -- Lesser Routes -- Perocular and Intraocular Routes -- Rectal Administration -- Vaginal Administration -- Nasal Administration -- Implantation -- Route Comparisons and Contrasts. , Volume Limitations by Route -- References -- Chapter 5: Delivery Systems -- Purposes -- Examples -- Liquid Formulation -- Instillation and Rhinyle Catheter -- Drops -- Powder Dosage Forms -- Insufflators and Mono-Dose Powder Inhaler -- Pressurized MDIs -- Nasal Gels -- Patented Nasal Formulations -- References -- Chapter 6: Dosing Regimens as a Means of Improving Drug Delivery and Tolerance -- References -- Chapter 7: The Utility of Circadian Oscillations in Formulation and Drug Development -- Background and Introduction -- Circadian Clock -- Reality of the Science of Timed Cyclical Rhythms -- Timed Rhythms and the Hepatic System -- Biological Rhythms in Species Other Than Mammals -- Biological Oscillations in Pharmacokinetics -- Timed Rhythms in Absorption -- Timed Patterns in the Absorption of Drugs -- Biological Rhythms and Heavy Metal Absorption -- Diurnal Rhythms and the Gastrointestinal Tract -- Internal Clock-Driven Rhythms and Distribution -- Diurnal Patterns and Excretion -- Internal Clock and the Renal System -- Biological Rhythms and Mixed-Function Oxidases -- Hepatic Conjugation Reactions and Diurnal Variations -- Biological Rhythms and the Otic System -- Patterns in Time and Other Physiologic Phenomena -- Internal Clock and Mathematical Modeling -- Conclusion -- References -- Chapter 8: Fundamentals of Nonclinical Formulation: Chemistry and Biological Behavior -- Mechanisms -- Preformulation -- Dermal Formulations -- Interactions between Skin, Vehicle, and Test Chemical -- Oral Formulations -- Parenteral Formulations -- Dosing Calculations -- Calculating Material Requirements -- Excipients -- Regulation of Excipients -- References -- Chapter 9: Vehicles and Excipients -- Excipients -- Vehicles -- Additional Readings -- References -- Chapter 10: Practical Ways of Improving Regional and Selective Drug Delivery -- Oral (PO). , Approaches to Improving Systemic Absorption -- Approaches to Improving Tolerance -- Approaches to Improving Target Tissue Section -- Intravenous (IV) -- Dermal -- Buccal/Sublingual -- Inhalation -- Nasal -- Bile Salts -- Cyclodextrins -- Viscosity Modifiers -- Mixed Micelles -- Formulation and Potential Mucosal Damage -- Rectal -- Vaginal and Uterine -- Ocular -- Subcutaneous (SC) -- Intramuscular (IM) -- Appendix: Vehicles and Excipients -- References -- Index.
    Additional Edition: Print version: Gad, Shayne C. Nonclinical Drug Administration : Formulations, Routes and Regimens for Solving Drug Delivery Problems in Animal Model Systems. Milton : CRC Press, ©2017 ISBN 9781466502536
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages